Form D Explorer

Inspect source fieldsReport a record issue

Form D — CNS Pharmaceuticals, Inc.

0001683168-26-004126 · filed May 19, 2026

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Pharmaceuticals filings

Offering

Industry
Pharmaceuticals
Exemptions
06b
Reported offering amount
$22,525,000
Reported amount sold
$22,525,000
Minimum investment
$0
Investors
13
Sales commission
$1,576,750
Finders' fees
$0

Issuer

Name
CNS Pharmaceuticals, Inc.
CIK
1729427
Entity
Corporation
Jurisdiction
NEVADA
Year incorporated
—
Address
2100 WEST LOOP SOUTH
HOUSTON, TX 77027
Phone
800-946-9185

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗